Delves into all aspects of R&D and manufacturing of all oral solid dose (OSD) forms. Tracks industry trends. Relays latest applied research relevant to OSDs. Provides “how to” information for the latest techniques in formulation/excipients, tablet manufacturing, capsule filling and other aspects of the process—including logistics like supply-chain management.
More than an ambition or just another formulation strategy, patient-centric drug design is the future of pharma. As emerging technologies make gathering and implementing user feedback simpler than ...
read more
While colors are up for interpretation, science generally is not. Health misinformation has always existed, but took centerstage during the pandemic when social media quickly became a powerful tool ...
read more
The first federal ban on a synthetic color due to the outdated Delaney Clause has inked a line in the sand — and crossing it could push the industry past the threshold of science-driven formulation ...
read more
Speed-to-market, efficiency, flexibility, quality. These aren’t just buzzwords — they’re critical goals every pharma manufacturer must achieve to bring new therapies to patients. The challenge lies in...
read more
Successfully navigating scale-up challenges in suppository drug products demands proactive regulatory planning, robust quality control approaches and cross-functional collaboration during technology ...
read more
Integrating spray dried dispersions with controlled release technologies offers a promising pathway to simultaneously address solubility limitations and the advantages of controlled release. The ...
read more
As we edge past the midpoint of 2025, the U.S. oral solid dose sector has already put up some regulatory wins. Here’s a closer look at this year's OSD approvals.
read more
Beyond Rule of Five compounds were once considered unlikely to demonstrate oral bioavailability. This article examines what bRo5 drugs are, how they are formulated, and the modern manufacturing ...
read more
As the pharmaceutical pipeline shifts increasingly toward low-solubility, low permeability compounds — especially in therapeutic areas such as oncology and antivirals — the need for practical, phase-...
read more
The U.S. government is currently investigating an ongoing antidumping and countervailing duty action looking into hard empty capsules from major trading partners.
read more
Repetitive, time-consuming tasks may seem tolerable for a small team filling small orders, however as demand surges, these tedious processes become bottlenecks impacting efficiency and capping profit ...
read more
As drugs have become increasingly complex, manufacturers have leaned on excipients to help improve drug formulations. Advancements in formulation science are pushing excipient innovation to the ...
read more
Drug product and capsule manufacturers need to stay abreast of new technologies to meet industry demand for innovative solutions.
read more
One could say that pharmaceutical excipients are the mild-mannered Clark Kents of drug formulation. Often described as ‘inactive’ ingredients, it’s easy to see how their role in the final drug product...
read more
As more potent and complex small molecules enter development, manufacturers face growing challenges in formulating them into effective oral drugs. Central to these hurdles is particle size control — a...
read more